This insight is of practical importance, as sorting of CD8+ T cells specific for a single type of antigenic peptide presented in both the ACT donor and recipient, or a single type of engineered viral epitope-specific TCR, should suffice for the control of the infection upon ACT. The gene discussed is CD8A; the disease is infection.